Carcinogenicity of the N-hydroxy derivative of 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine, 2-amino-3,8-dimethyl-imidazo[4,5-f]quinoxaline and 3,2'-dimethyl-4-aminobiphenyl in the rat

Cancer Letters

Volumn 155, Issue 1, 2000, Pages 55-60

  Archer, Corlis L ^a   Morse, Philo ^a   Jones, Richard F ^a   Shirai, Tomoyuki ^b   Haas, G P ^a   Wang, C Y ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

2 Amino 1 methyl 6 phenylimidazo 4,5 b pyridine; 2 Amino 3,8 dimethylimidazo 4,5 f quinoxaline; 3,2' Dimethyl 4 aminobiphenyl; Carcinogenicity; Colon; Prostate; Urinary bladder

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; 2 AMINO 3,8 DIMETHYLIMIDAZO[4,5 F]QUINOXALINE; 2',3 DIMETHYL 4 BIPHENYLAMINE; AROMATIC AMINE; HETEROCYCLIC AMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENICITY; COLON CARCINOMA; CONTROLLED STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RAT; TRANSITIONAL CELL CARCINOMA;

AMINOBIPHENYL COMPOUNDS; ANIMALS; ANIMALS, NEWBORN; BODY WEIGHT; CARCINOGENS; CARCINOMA, TRANSITIONAL CELL; COLONIC NEOPLASMS; HYPERPLASIA; IMIDAZOLES; MALE; MUTAGENS; PROSTATIC NEOPLASMS; PYRIDINES; QUINOXALINES; RATS; RATS, INBRED ACI; URINARY BLADDER NEOPLASMS;

ANIMALIA;

EID: 0034601229     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(00)00413-4     Document Type: Article

References (22)

1. Silverman D.T., Hartge P., Morrison A.S., Devesa S.S. Epidemiology of bladder cancer. Hematol. Oncol. Clin. North Am. 6:1992;1-30.
2. Bruemmer B., White E., Vaughan T.L., Cheney C.L. Nutrient intake in relation to bladder cancer among middle-aged men and women. Am. J. Epidemiol. 144:1996;485-495.
3. Felton J.S., Malfatti M.A., Knize M.G., Salmon C.P., Hopmans E.C., Wu R.W. Health risks of heterocyclic amines. Mutat. Res. 376:1997;37-41.
4. Ito N., Hasegawa R., Imaida K., Tamano S., Hagiwara A., Hirose M., Shirai T. Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the rat. Mutat. Res. 376:1997;107-114.
5. Shirai T., Sano M., Tamano S., Takahashi S., Hirose M., Futakuchi M., Hasegawa R., Imaida K., Matsumoto K., Wkabayashi K., Sugimura T., Ito N. The prostate: a target for carcinogenicity of 2-amino-1-methyl-6-phenylimidazo(4,5-b) pyridine (PhIP) derived from cooked foods. Cancer Res. 57:1997;195-198.
6. el-Bayoumy K., Chae Y-H., Upadhyaya P., Rivenson A., Kurtzke C., Reddy B., Hecht S.S. Comparative tumorigenicity of benzo[a]pyrene, 1-nitropyrene and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine administered by gavage to female CD rats. Carcinogenesis. 16:1995;431-434.
7. Ghoshal A., Preisegger K-H., Takayama S., Thorgeirsson S.S., Snyderwine E.G. Induction of mammary tumors in female Sprague-Dawley rats by the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and effect of dietary fat. Carcinogenesis. 15:1994;2429-2433.
8. Kato T., Ohgaki H., Hasegawa H., Sato S., Takayama S., Sugimura T. Carcinogenicity in rats of a mutagenic compound, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. Carcinogenesis. 9:1988;71-73.
9. Lang N.P., Nowell S., Malfatti M.A., Kulp K.S., Knize M.G., Davis C., Massengill J., Williams S., MacLeod S., Dingley K.H., Felton J.S., Turteltaub K.W. In vivo human metabolism of [2-C-14]2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine (PhIP). Cancer Lett. 143:1999;135-138.
10. Kadlubar F.F. Biochemical individuality and its implications for drug and carcinogen metabolism: recent insights from acetyltransferase and cytochrome P4501A2 phenotyping and genotyping in humans. Drug Metab. Rev. 26:1994;37-46.
11. King C.M., Land S.J., Jones R.F., Debiec-Rychter M., Lee M.-S., Wang C.Y. Role of acetyltransferases in the metabolism and carcinogenicity of aromatic amines. Mutat. Res. 376:1997;123-128.
12. Shirai T., Nakamura A., Fukushima S., Yamamoto A., Tada M., Ito N. Different carcinogenic responses in a variety of organs, including prostate, of five different rat strains given 3,2′-dimethyl-4-aminobiphenyl. Carcinogenesis. 11:1990;793-797.
13. Shirai T., Nakamura A., Fukushima S., Wang C.Y., Yamada H., Ito N. Selective induction of prostate carcinomas in F344 rats treated with intraperitoneal injection of N-hydroxy-3,2′dimethyl-4-aminobiphenyl. Jpn. J. Cancer Res. 81:1990;320-323.
14. Wang C.Y., Debiec-Rychter M., Schut H.A.J., Morse P., Jones R.F., Archer C., King C.M., Haas G.P. N-Acetyltransferase expression and DNA binding of N-hydroxyheterocyclic amines in human prostate epithelium. Carcinogenesis. 20:1999;1591-1595.
15. Ward J.M., Reznik G., Stinson S.F., Lattuada C.P., Longfellow D.G., Cameron T.P. Histogenesis and morphology of naturally occurring prostatic carcinoma in the ACI/segHapBR rat. Lab. Invest. 43:1980;517-522.
16. Takahashi S., Tamano S., Hirose M., Kimoto N., Ikeda Y., Sakakibara M., Tada M., Kadlubar F.F., Ito N., Shirai T. Immunohistochemical demonstration of carcinogen-DNA adducts in tissues of rats given 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP): detection in paraffin-embedded sections and tissue distribution. Cancer Res. 58:1998;4307-4313.
17. Wang C.Y., Zukowski K., Imaida K., Lee M.S. Effects of arylamine urinary metabolites on urothelial cells. King C.M., Romano L.J. Carcinogenic and Mutagenic Responses to Aromatic Amines and Nitroarenes. 1988;227-236 Elsevier, Ireland.
18. Takahashi M., Toyoda K., Aze Y., Furuta K., Mitsumori K., Hayashi Y. The rat urinary bladder as a new target of heterocyclic amine carcinogenicity: tumor induction by 3-amino-1-methyl-5H-pyrido[4,3-b]indole acetate. Jpn. J. Cancer Res. 84:1993;852-858.
19. Shirai T., Iwasaki S., Naito H., Masui T., Kato T., Imaida K. Dose dependence of N-hydroxy-3,2′-dimethyl-4-aminobiphenyl-induced rat prostate carcinogenesis. Jpn. J. Cancer Res. 83:1992;695-698.
20. Shirai T., Fukushima S., Ikawa E., Tagawa Y., Ito N. Induction of prostate carcinoma in situ at high incidence in F344 rats by a combination of 3,2′-dimethyl-4aminobiphenyl and ethinyl estradiol. Cancer Res. 6:1986;6423-6426.
21. Takai K., Kakizoe T., Tanaka Y., Tobisu K., Aso Y. Trial to induce prostatic cancer in ACI/seg rats treated with a combination of 3,2-dimethyl-4-aminobiphenyl and ethinyl estradiol. Jpn. J. Cancer Res. 82:1991;286-292.
22. Isaacs J.T. The aging ACI/seg vs. Copenhagen male rat as a model system for the study of prostatic carcinogenesis. Cancer Res. 44:1984;5784-5796.